Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

chlorzoxazone

chlorzoxazone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Lorzone TABLET, ORAL 375 mg, 750 mg    
Parafon Forte TABLET, ORAL 500 mg      
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

chlorzoxazone (Lorzone)

  • 375 mg once Daily
  • 375 mg BID
  • 375 mg TID
  • 375 mg QID
  • 750 mg once Daily
  • 750 mg BID
  • 750 mg TID
  • 750 mg QID

chlorzoxazone (Parafon Forte)

  • 500 mg once Daily
  • 500 mg BID
  • 500 mg BID
  • 500 mg TID
  • 500 mg BID
  • 500 mg TID
  • 500 mg QID
  • 500 mg q4 hours, while awake

Chlorzoxazone 500 mg is approved for formulary status. LORZONE (375 mg and 750 mg) is classified as non-formulary, not stocked for hospital inpatient and outpatient status. For inpatients, these strengths are interchanged to the 500 mg tablets.

Reviewed: October 22, 2013 (Lorzone)

Last updated: Aug. 23, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved